Additionally, VEGF can stimulate tumor cells in an autocrine manner, and bevacizumab resistance has been associated with upregulation of VEGF and its receptors VEGFR1 and VEGFR2 by tumor cells [37,38]. The gene discussed is FLT1; the disease is neoplasm.